SCHEMBL25580498

SCHEMBL25580498

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2ccc(N(c3ccc(-c4cccc5c4oc4ccccc45)cc3)c3cccc(-c4cccc5ccccc45)c3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.46
▸ GGPS1 O95749 1/20 0.39
▸ PRKDC P78527 4/20 0.36
▸ PTGES2 Q9H7Z7 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ ACMSD Q8TDX5 1/20 0.36
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ PRMT5 O14744 1/20 0.33
▸ WDR77 Q9BQA1 1/20 0.33
▸ EDNRB P24530 1/20 0.32
▸ EDNRA P25101 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580802 1.00 ALOX5 (0.46) ALOX5GGPS1PRKDCPTGES2MCL1
SCHEMBL25581014 1.00 ALOX5 (0.46) ALOX5GGPS1PRKDCPTGES2MCL1
SCHEMBL23225022 0.94 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2MCL1
SCHEMBL25580991 0.94 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2PRMT5
SCHEMBL25581046 0.94 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2PRMT5
SCHEMBL25580742 0.94 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL18383255 0.93 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2MCL1
SCHEMBL23225360 0.93 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2MCL1
SCHEMBL10110142 0.93 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2MCL1
SCHEMBL23224725 0.93 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885GGPS1 4169/4885PRKDC 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback